| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3739530
Max Phase: Preclinical
Molecular Formula: C26H20Br2N2O
Molecular Weight: 536.27
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(Nc1ccccc1)c1ccc(NC(c2ccc(Br)cc2)c2ccc(Br)cc2)cc1
Standard InChI: InChI=1S/C26H20Br2N2O/c27-21-12-6-18(7-13-21)25(19-8-14-22(28)15-9-19)29-24-16-10-20(11-17-24)26(31)30-23-4-2-1-3-5-23/h1-17,25,29H,(H,30,31)
Standard InChI Key: IWBBDNIDCZTOEB-UHFFFAOYSA-N
Associated Targets(Human)
Prenyl protein specific protease 365 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 536.27 | Molecular Weight (Monoisotopic): 533.9942 | AlogP: 7.67 | #Rotatable Bonds: 6 |
| Polar Surface Area: 41.13 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
| #RO5 Violations: 2 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: | CX Basic pKa: 1.25 | CX LogP: 7.58 | CX LogD: 7.58 |
| Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.27 | Np Likeness Score: -1.13 |
References
| 1. Mohammed I, Hampton SE, Ashall L, Hildebrandt ER, Kutlik RA, Manandhar SP, Floyd BJ, Smith HE, Dozier JK, Distefano MD, Schmidt WK, Dore TM.. (2016) 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells., 24 (2): [PMID:26706114] [10.1016/j.bmc.2015.11.043] |
Source
Source(1):